Correlation Between Sana Biotechnology and Intellia Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sana Biotechnology and Intellia Therapeutics, you can compare the effects of market volatilities on Sana Biotechnology and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Intellia Therapeutics.

Diversification Opportunities for Sana Biotechnology and Intellia Therapeutics

0.92

Correlation Coefficient

Sana Biotechnology  Intellia Therapeutics

Almost no diversification

The 3 months correlation between Sana and Intellia is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Intellia Therapeutics go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Intellia Therapeutics

Given the investment horizon of 90 days Sana Biotechnology is expected to generate 1.22 times more return on investment than Intellia Therapeutics. However, Sana Biotechnology is 1.22 times more volatile than Intellia Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about 0.18 per unit of risk. If you would invest  170.00  in Sana Biotechnology on May 7, 2025 and sell it today you would earn a total of  253.00  from holding Sana Biotechnology or generate 148.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Sana Biotechnology  vs.  Intellia Therapeutics

Sana Biotechnology

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Intellia Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Intellia Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain essential indicators, Intellia Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sana Biotechnology and Intellia Therapeutics

The main advantage of trading using opposite Sana Biotechnology and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.

The idea behind Sana Biotechnology and Intellia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.